AlphaStocks
5.3
Consider Buy

Cigna Group (CI)

As of Sep 20, 2026, Cigna Group (CI) scores 5.3/10 on AlphaStocks' five-model composite, #94 of 168 Health Care stocks. At $275, CI trades 36% below its model fair value of $430.

Health Care / Health Care Services

S&P 500

$275.27

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#94out of 168 in Health Care

Is Cigna Group a Good Investment in 2026?

Cigna Group (CI) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Cigna Group as Strong (8/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. Cigna Group currently trades 36% below its estimated fair value of $430. Cigna Group ranks #94 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E12.4ROE14.3Market Cap73BDiv Yield2.0

Estimated Fair Value

$430.0236% below

Trading below estimated fair value. EPS grew 83% year-over-year. P/E of 12x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

5% above fair value

Lynch

Neutral

PEG 2.0 · Stalwart

Greenblatt

Neutral

Earnings yield 12.2% · ROC 12%

Frequently Asked Questions

Is Cigna Group (CI) a good investment?
As of Sep 20, 2026, Cigna Group (CI) scores 5.3/10 on AlphaStocks' five-model composite, #94 of 168 Health Care stocks. At $275, CI trades 36% below its model fair value of $430. That score is below average, suggesting caution.
What is Cigna Group's Piotroski F-Score?
Cigna Group's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CI overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $430, CI appears undervalued. The stock currently trades 36% below its estimated fair value. Trading below estimated fair value. EPS grew 83% year-over-year. P/E of 12x is moderate for this quality level.
How does CI compare to other Health Care stocks?
Cigna Group ranks #94 out of 168 stocks in the Health Care sector, placing it in the top 56% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CI?
AlphaStocks evaluates CI using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.3/10.

Similar Stocks

DVAMDDGX

Compare CI with

CI vs DVACI vs MDCI vs DGXCI vs VALAZN vs CICI vs PARR

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer